Table 1.
KEGG pathway analysis of the DEGs.
| ID | Term | P value | DEGs |
| hsa05020 | Prion diseases | .000256006 | EGR1,C7,HSPA1A,C1QC |
| hsa05150 | Staphylococcus aureus infection | .000349668 | C3,FPR1,FPR3,DEFA1B,C1QC |
| hsa00010 | Glycolysis/Gluconeogenesis | .000349668 | G6PC,ADH1B,ALDOB,PCK1,FBP11 |
| hsa00360 | Phenylalanine metabolism | .000429976 | PAH,GLYAT,HPD |
| hsa04657 | IL-17 signaling pathway | .001458378 | CCL2,FOS,PTGS2,S100A9,S100A8 |
| hsa00980 | Metabolism of xenobiotics by | .004299684 | CYP2B6,ADH1B,GSTA2,GSTA1 |
| cytochrome P450 | |||
| hsa05204 | Chemical carcinogenesis | .006187546 | ADH1B,GSTA2,GSTA1,PTGS2 |
| hsa04062 | Chemokine signaling pathway | .007173479 | CXCR1,CCL21,CXCR2,CCL2, CCL19, CCL18 |
| hsa05418 | Fluid shear stress and atherosclerosis | .008143607 | DUSP1,GSTA2,GSTA1,CCL2,FOS |
| hsa00330 | Arginine and proline metabolism | .00946077 | SAT2,PRODH2,AGMAT |
| hsa04933 | AGE-RAGE signaling pathway | .012269268 | EGR1,COL1A2,FN1,CCL2 |
| hsa03008 | Ribosome biogenesis in eukaryotes | .012688633 | SNORD3B-2,SNORD3B-1 |
| SNORD3C, SNORD3A | |||
| hsa00983 | Drug metabolism | .015881308 | CYP2B6,ADH1B,GSTA2,GSTA1 |
| hsa04060 | Cytokine-cytokine receptor interaction | .016421793 | CXCR1,CCL21,CXCR2,CCL2, A;CCL19;CCL18 |
| interaction | INHBA, CCL19, CCL18 | ||
| hsa04668 | TNF signaling pathway | .016877923 | CCL2,FOS,PTGS2,JUNB |